Expression of glucose transporters in human neurodegenerative diseases

被引：27

作者：

Gluchowska, Kinga ^{[1
]}

Pliszka, Monika ^{[1
]}

Szablewski, Leszek ^{[1
]}

机构：

[1] Med Univ Warsaw, Chair & Dept Gen Biol & Parasitol, 5 Chalubinskiego Str, PL-02004 Warsaw, Poland

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2021年 / 540卷

关键词：

Glucose transporters; Glucose metabolism; Alzheimer's diseases; Huntington's disease; Parkinson's disease;

D O I：

10.1016/j.bbrc.2020.12.067

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The central nervous system (CNS) plays an important role in the human body. It is involved in the receive, store and participation in information retrieval. It can use several substrates as a source of energy, however, the main source of energy is glucose. Cells of the central nervous system need a continuous supply of energy, therefore, transport of glucose into these cells is very important. There are three distinct families of glucose transporters: sodium-independent glucose transporters (GLUTs), sodium-dependent glucose cotransporters (SGLTs), and uniporter, SWEET protein. In the human brain only GLUTs and SGLTs were detected. In neurodegenerative diseases was observed hypometabolism of glucose due to decreased expression of glucose transporters, in particular GLUT1 and GLUT3. On the other hand, animal studies revealed, that increased levels of these glucose transporters, due to for example by the increased copy number of SLC2A genes, may have a beneficial effect and may be a targeted therapy in the treatment of patients with AD, HD and PD. (C) 2020 Published by Elsevier Inc.

引用

页码：8 / 15

页数：8

共 143 条

[71] Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease [J].